Study Of Sunitinib In Combination With Cisplatin/Capecitabine Or Oxaliplatin/Capecitabine In Patients With Advanced Gastric Cancer

NCT00555620 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

76

Enrollment

INDUSTRY

Sponsor class

Conditions

Stomach Neoplasms

Interventions

DRUG: capecitabine
DRUG: oxaliplatin
DRUG: sunitinib malate
DRUG: capecitabine
DRUG: cisplatin
DRUG: sunitinib malate

Sponsor

Pfizer